Navigation Links
Genencor Shows How Industrial Biotech Breakthroughs Contribute to the New Green Economy
Date:3/20/2009

Event showcases sustainable solutions for biofuels, biochemicals and textile processing

PALO ALTO, Calif., March 20 /PRNewswire-USNewswire/ -- Yesterday, Genencor, a division of Danisco A/S, hosted a private tour of its Bay Area Research and Development headquarters to a group of industry influencers and media. The tour showcased recently announced collaborations for developing sustainable fuels, chemicals, and other products that will reduce greenhouse gas emissions and contribute to energy independence by using renewable raw materials.

The event profiled three Genencor initiatives launched in the past 10 months - its joint venture, DuPont Danisco Cellulosic Ethanol (DDCE); collaboration with The Goodyear Tire & Rubber Company to make BioIsoprene(TM) (a synthetic rubber alternative); and collaboration with Huntsman Textile Effects on a biobased bleaching process.

"We're joining forces with major industry players to tackle today's most pressing global challenges - how to use renewable raw materials to make the fuels and materials advance society's need," Genencor CEO Tjerk de Ruiter says. "In doing this, we are pointing to exciting new opportunities for growing American, and global, prosperity in the green economy."

"The initiatives with DuPont and Goodyear are pointing the way to a new economy," says Genencor's Executive Vice President of Business Development Philippe Lavielle. "This includes delivering a reliable supply of fuel made from biomass and a renewable biobased alternative to a key petrochemical in synthetic rubber production. We're meeting the technical milestones to get these projects to demonstration scale for fast-track commercialization. They represent the vast potential for biorefineries."

"DDCE's Vonore, Tennessee, demo plant is on track for completion in 2010," said DDCE CEO Joseph Skurla. "Within two to three years people will be fueling their tanks with ethanol made from corn cobs and switchgrass."

Today's event, co-hosted by BayBio, Northern California's life sciences association, brought together top executives at Genencor and its collaborators, including Skurla and The Goodyear Tire & Rubber Co.'s Director, Global Materials Science, Jesse Roeck, as well as representatives of the Bay Area's biotech activities.

"Northern California's cluster of life sciences companies is the biggest in the U.S. Genencor is one on of the pioneers in the area that are tackling critical industrial challenges through biotechnology," says Matthew Gardner, President and CEO of BayBio, who moderated an executive panel. "They represent a shift toward applying science to building the green economy, which will help spur economic growth in California and nationally."

Showcase highlights interactive biorefinery demo

A highlight of the event was an interactive demo that gave participants a firsthand look at how cellulosic biomass, such as sugarcane bagasse, and corn cobs, is converted into many useful products. Like oil refineries, biorefineries will produce many different end-products, but with renewable feedstocks that reduce dependence on fossil fuels, increase national security, and reduce natural resource consumption and greenhouse gas emissions. The demo illustrated that these technologies are in advanced stages. Cellulosic ethanol will supply commercial volumes in the next two to three years, and Genencor just made its first delivery of BioIsoprene to The Goodyear Tire and Rubber Co. on March 9, 2009.

During a tour of the R&D facility, participants got a look at how Genencor scientists and technicians engineer molecules and enzymes and scale them up quickly for mass production. "Our cell factories are our core competence," says de Ruiter. "Every day we are supplying industries with enzymes to run their processes, while at the same time pushing boundaries to make better industries and more sustainable societies."

Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries, from biofuels and laundry detergents to animal nutrition and food. As part of a large global organization, Genencor has a manufacturing and distribution network that spans more than 40 countries. In collaboration with customers, technology leaders and other stakeholders, Genencor supplies competitive, biobased solutions. These innovations create value throughout the supply chain, from raw material to finished product.


'/>"/>
SOURCE Genencor
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
2. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
3. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
4. Genencor Appoints New Executive Vice President - Technical Enzymes
5. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
6. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
7. Study Shows Machine Perfusion Significantly Improves Transplant Results
8. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
9. NPL research shows there could be no end in sight for Moore’s Law
10. Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
11. OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... February 27, 2017 A Europe-wide survey of ... researchers using animals in their research treat them with due care. ... and detailed analysis of the results indicates that there is a ... to put into practice the principles of the 3Rs (Refine, ... What ...
(Date:2/27/2017)... Feb. 27, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... the U.S. Food and Drug Administration (FDA) has ... section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil sublingual ... with moderate-to-severe acute pain in a medically supervised ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire ... grandfather, “Hire for attitude. Train for skill.” , In keeping with this philosophy, the ... as a salesman. Zamzow is hoping to replicate the practice throughout the company. , ...
Breaking Biology Technology:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):